Tag:
stroke
Latest Headlines
Latest Headlines
Proteome Sciences shares jump on licensing deal
Proteome Sciences shares rose by 14.9 percent when the news of its stroke biomarkers licensing agreement with Randox Laboratories broke.
FDA could revoke Stryker Wingspan brain stent approval
Stryker's Wingspan intracranial stent faces an uncertain future in the U.S. market.
FDA knocks Stryker's Wingspan stent
Stryker is facing a sobering FDA report that points to the company's Wingspan stent as being more damaging than helpful in some cases and of neutral benefit in others, according to a Bloomberg story.
Triglycerides more accurate than cholesterol at marking stroke
Traditionally, blood cholesterol levels have been used to determine the risk of stroke. However, a recent study suggests this approach may be underestimating the risk in a specific
Gene expression in TIA could lead to biomarkers
Transient ischemic attacks (TIAs), sometimes described as mini-strokes, are caused by brief interruptions in the blood flow. The symptoms can be similar to those of strokes, but resolve within 24
Biomarker could quickly diagnose stroke patients
Testing for the NR2 peptide can identify patients suffering from acute ischemic stroke within 24 hours of the onset of symptoms, reports Medscape Today. The findings are backed by neuroimaging
Chocolate – the miracle drug?
In Woody Allen's 1973 movie "Sleeper," the main character awakens from a long sleep to find out that the world is a radically changed place. What everyone thought was bad for you actually turned out
Biotechs grab funds for drugs that cross brain barrier
European biotech NeuroVive and to-BBB technologies have found funds for a novel stroke therapy. Eurostars, a program that funds business activity in Europe, has awarded €500,000 to each of the
Biomarkers could predict stroke, TBI risk
With the help of a $1.47 million NIH grant, Emory University researchers are studying whether they can detect biomarkers in the bloodstream after a person has suffered a stroke. They want to
J&J's blockbuster hopeful Xarelto bounces back with AdComm backing
The blood thinner Xarelto came through an FDA advisory committee meeting looking better than some had expected. The AdComm backed approval of the potential blockbuster for preventing stokes in
